The fight against Covid-19: The risk impacts on healthcare

Covid-19 has presented life science companies around the world with a set of new and evolving challenges.

As we are now seeing members of the public receiving a vaccination, Stephanie Bristow, Class Underwriter, Healthcare London, London Wholesale at AXA XL, discusses the new risks life sciences companies are facing and how risk engineering and transfer is playing a part in helping to manage them.